Liminatus Pharma Surges Over 5% After Announcing $500M BNB Investment Strategy
View all comments(0)
TradingKey – On Monday, July 28, Nasdaq-listed Liminatus Pharma Inc. (LIMN) jumped 5.28% in pre-market trading after unveiling plans to launch a dedicated crypto subsidiary focused on Binance Coin (BNB).

Liminatus Pharma Stock Chart – Source: Google
Liminatus, a preclinical-stage cancer immunotherapy company, announced it will form a new subsidiary called “American BNB Strategy” to manage and invest in BNB, the native token of the Binance ecosystem.
- The company aims to raise up to $500 million, deploying funds in phased investments targeting long-term BNB accumulation
- This move positions Liminatus alongside other corporate BNB holders like Nano Labs (NA), which currently holds 128,000 BNB
Coincidentally, the price of BNB soared above $850 today, setting a new record high. In the past 24 hours, BNB rose by more than 6%, reaching a high of $859 and temporarily reported at $849.

BNB price chart (1 hour), source: TradingView
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Nvidia’s Trillion-Dollar Market Value Stock Price Flash Crashes, Intraday Drop Exceeds 4.6%. What Are the Reasons?

SpaceX to IPO in June, How Ordinary Investors Seize the Last Opportunity?

SpaceX IPO Date Moved Up to June 12: What Should Investors Watch? How Can European and Asian Investors Buy SpaceX Shares? What Is the Impact on Broad US Markets?

Palantir Grew Revenue 85% and Raised Full-Year Guidance by 10 Points — So Why Is PLTR Down 26% YTD?

SanDisk Is Up 509% YTD After a 251% Revenue Beat - Is the Pullback to $1,382 a Buying Opportunity?

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.